PROTECTIVE EFFECT OF JIAOGULAN ON CELLULAR IMMUNITY OF THE PATIENTS WITH PRIMARY LUNG CANCER TREATED BY RADIOTHERAPY PLUS CHEMOTHERAPY
Qian Hao; Fu Shen; Jiang Guoliang; Wang Lijuan;Fu Xiaolong; Ye Ming; Zhao Sen(Cancer Hospital,Shanghai Medical University, Shanghai)
The aim of the clinical trial in the patients with lung cancer treated by combined radiotherapy and chemotherapy was to prospectively observe the effect of jiaogulan on the cellular immunity and prognosis.The results: cellular immunity of the control group was further suppressed;when the patients take jiaogulan tables(180～240mg/day) during the therapy period (60 days) the immune situation could keep no change. Comparing the jiaogulan group with the control group after a year,although there were no significant differences in statistics on the distant metastatic rate,the medial time of distant metastasis and the local tumor control rate and survival rate of 6 and 12 months respectively, but the trend that the prognosis of the former was superior to the latter could be found.The results show that jiaogulan can protect patient's cellular immunity when the patients receiving radiotherapy plus chemotherapy.
【CateGory Index】： R273.42